Log in

NASDAQ:FBIOFortress Biotech News Headlines

$2.69
-0.03 (-1.10 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.58
Now: $2.69
$2.72
50-Day Range
$2.54
MA: $2.82
$3.16
52-Week Range
$1.04
Now: $2.69
$3.20
Volume604,114 shs
Average Volume1.10 million shs
Market Capitalization$221.84 million
P/E RatioN/A
Dividend YieldN/A
Beta2.19

Headlines

Fortress Biotech (NASDAQ FBIO) News Headlines

Source:
DateHeadline
FY2021 Earnings Forecast for Fortress Biotech (NASDAQ:FBIO) Issued By Cantor FitzgeraldFY2021 Earnings Forecast for Fortress Biotech (NASDAQ:FBIO) Issued By Cantor Fitzgerald
www.americanbankingnews.com - July 3 at 7:18 AM
Fortress Biotech Added to Russell 3000(R) IndexFortress Biotech Added to Russell 3000(R) Index
www.marketwatch.com - June 29 at 2:16 PM
Fortress Biotech Added to Russell 3000® IndexFortress Biotech Added to Russell 3000® Index
finance.yahoo.com - June 29 at 9:16 AM
United Therapeutics (NASDAQ:UTHR) and Fortress Biotech (NASDAQ:FBIO) Critical ComparisonUnited Therapeutics (NASDAQ:UTHR) and Fortress Biotech (NASDAQ:FBIO) Critical Comparison
www.americanbankingnews.com - June 27 at 11:33 AM
Zacks: Analysts Anticipate Fortress Biotech (NASDAQ:FBIO) Will Post Quarterly Sales of $11.59 MillionZacks: Analysts Anticipate Fortress Biotech (NASDAQ:FBIO) Will Post Quarterly Sales of $11.59 Million
www.americanbankingnews.com - June 23 at 6:08 AM
 Analysts Anticipate Fortress Biotech (NASDAQ:FBIO) to Post -$0.28 EPS Analysts Anticipate Fortress Biotech (NASDAQ:FBIO) to Post -$0.28 EPS
www.americanbankingnews.com - June 21 at 1:23 PM
Fortress Biotech (NASDAQ:FBIO) Sees Large Decline in Short InterestFortress Biotech (NASDAQ:FBIO) Sees Large Decline in Short Interest
www.americanbankingnews.com - June 18 at 6:37 PM
Fortress Biotech to Present at the Raymond James Human Health Innovation ConferenceFortress Biotech to Present at the Raymond James Human Health Innovation Conference
www.benzinga.com - June 15 at 8:39 AM
Short Interest in Fortress Biotech (NASDAQ:FBIO) Decreases By 28.4%Short Interest in Fortress Biotech (NASDAQ:FBIO) Decreases By 28.4%
www.americanbankingnews.com - June 11 at 12:34 AM
Here is What Hedge Funds Think About Fortress Biotech Inc (FBIO)Here is What Hedge Funds Think About Fortress Biotech Inc (FBIO)
finance.yahoo.com - June 10 at 5:26 PM
Fortress Biotech (NASDAQ:FBIO) Receives Average Recommendation of "Buy" from AnalystsFortress Biotech (NASDAQ:FBIO) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 10 at 2:00 AM
Will Fortress Biotech Incs price keep soaring?Will Fortress Biotech Inc's price keep soaring?
uk.finance.yahoo.com - June 9 at 7:31 AM
Fortress Biotech to Host Virtual Annual Meeting of StockholdersFortress Biotech to Host Virtual Annual Meeting of Stockholders
www.marketwatch.com - June 2 at 9:46 AM
Hedge Funds Watching Avenue Therapeutics, Inc. (ATXI) From AfarHedge Funds Watching Avenue Therapeutics, Inc. (ATXI) From Afar
finance.yahoo.com - May 27 at 12:47 PM
Fortress Biotech prices Series A preferred stock offeringFortress Biotech prices Series A preferred stock offering
seekingalpha.com - May 27 at 7:47 AM
Fortress Bio closes license deal with Columbia U. for cancer candidatesFortress Bio closes license deal with Columbia U. for cancer candidates
seekingalpha.com - May 8 at 5:48 PM
Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University to Develop Novel Oligonucleotide Platform for the Treatment of Genetically Driven CancersFortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University to Develop Novel Oligonucleotide Platform for the Treatment of Genetically Driven Cancers
finance.yahoo.com - May 8 at 5:48 PM
Checkpoint Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate HighlightsCheckpoint Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
finance.yahoo.com - May 7 at 3:19 AM
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Fortress Biotech, Inc. for Potential Breach of Fiduciary Duty Claims.INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Fortress Biotech, Inc. for Potential Breach of Fiduciary Duty Claims.
finance.yahoo.com - April 30 at 4:07 PM
Checkpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Anti-PD-L1 Antibody CosibelimabCheckpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Anti-PD-L1 Antibody Cosibelimab
finance.yahoo.com - April 21 at 8:46 AM
Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined ImmunodeficiencyMustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency
finance.yahoo.com - April 20 at 12:44 PM
Fortress Biotech Announces Up to $5 Million Series A Cumulative Redeemable Perpetual Preferred Stock Repurchase ProgramFortress Biotech Announces Up to $5 Million Series A Cumulative Redeemable Perpetual Preferred Stock Repurchase Program
finance.yahoo.com - March 23 at 10:22 AM
Analysts Are Upgrading Fortress Biotech, Inc. After Its Latest ResultsAnalysts Are Upgrading Fortress Biotech, Inc. After Its Latest Results
finance.yahoo.com - March 18 at 7:21 AM
Fortress Biotech EPS misses by $0.01, beats on revenueFortress Biotech EPS misses by $0.01, beats on revenue
seekingalpha.com - March 17 at 12:45 AM
Fortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate HighlightsFortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Highlights
finance.yahoo.com - March 17 at 12:45 AM
Checkpoint Therapeutics Reports Full-Year 2019 Financial Results and Recent Corporate HighlightsCheckpoint Therapeutics Reports Full-Year 2019 Financial Results and Recent Corporate Highlights
finance.yahoo.com - March 11 at 5:54 PM
Fortress Biotech Announces Closing of Series A Preferred Stock Offering and Full Exercise of Over-Allotment OptionFortress Biotech Announces Closing of Series A Preferred Stock Offering and Full Exercise of Over-Allotment Option
finance.yahoo.com - February 24 at 8:13 AM
NetworkNewsBreaks - Fortress Biotech, Inc. FBIO Featured in ROTH Equity Research ReportNetworkNewsBreaks - Fortress Biotech, Inc. FBIO Featured in ROTH Equity Research Report
www.marketwatch.com - February 13 at 2:06 PM
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDAAvenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
finance.yahoo.com - February 13 at 9:05 AM
Fortress Biotech prices equity offeringFortress Biotech prices equity offering
seekingalpha.com - February 12 at 8:21 AM
Loss-Making Fortress Biotech, Inc. (NASDAQ:FBIO) Expected To BreakevenLoss-Making Fortress Biotech, Inc. (NASDAQ:FBIO) Expected To Breakeven
finance.yahoo.com - January 17 at 8:59 AM
Fortress Biotech Announces Rare Pediatric Disease Designation for CUTX-101 for the Treatment of Menkes DiseaseFortress Biotech Announces Rare Pediatric Disease Designation for CUTX-101 for the Treatment of Menkes Disease
finance.yahoo.com - January 16 at 1:12 PM
Cincinnati Children’s strikes deal with pharma firmsCincinnati Children’s strikes deal with pharma firms
www.bizjournals.com - December 23 at 1:05 PM
Fortress Bio in-licenses rights for AstraZenecas AZD7325Fortress Bio in-licenses rights for AstraZeneca's AZD7325
seekingalpha.com - December 23 at 1:05 PM
Fortress Biotech Announces Exclusive Worldwide License Agreement With AstraZeneca and Cincinnati Children’s Hospital Medical Center to Develop a Novel Treatment for Select CNS DisordersFortress Biotech Announces Exclusive Worldwide License Agreement With AstraZeneca and Cincinnati Children’s Hospital Medical Center to Develop a Novel Treatment for Select CNS Disorders
finance.yahoo.com - December 23 at 1:05 PM
Hedge Funds Have Never Been This Bullish On Fortress Biotech Inc (FBIO)Hedge Funds Have Never Been This Bullish On Fortress Biotech Inc (FBIO)
finance.yahoo.com - December 16 at 8:11 AM
Fortress Biotech (FBIO) Investor Presentation - SlideshowFortress Biotech (FBIO) Investor Presentation - Slideshow
seekingalpha.com - December 13 at 5:52 PM
Avenue Therapeutics Announces Submission of New Drug Application for IV TramadolAvenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
finance.yahoo.com - December 11 at 8:43 AM
Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined ImmunodeficiencyMustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency
finance.yahoo.com - December 9 at 8:01 AM
Fortress Biotech to Participate in December 2019 Investor ConferencesFortress Biotech to Participate in December 2019 Investor Conferences
finance.yahoo.com - December 2 at 9:12 AM
Mustang Bio to Participate in the Evercore ISI 2nd Annual HealthCONx ConferenceMustang Bio to Participate in the Evercore ISI 2nd Annual HealthCONx Conference
finance.yahoo.com - December 2 at 9:12 AM
Fortress Biotech Announces Pricing of Series A Preferred Stock OfferingFortress Biotech Announces Pricing of Series A Preferred Stock Offering
finance.yahoo.com - November 26 at 12:11 AM
Checkpoint Therapeutics Announces Proposed Public Offering of Common StockCheckpoint Therapeutics Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 19 at 5:26 PM
Fortress Biotech Ranked in Top 10 of Deloittes 2019 Technology Fast 500(TM)Fortress Biotech Ranked in Top 10 of Deloitte's 2019 Technology Fast 500(TM)
www.marketwatch.com - November 14 at 4:10 PM
Fortress Biotech Ranked in Top 10 of Deloitte’s 2019 Technology Fast 500™Fortress Biotech Ranked in Top 10 of Deloitte’s 2019 Technology Fast 500™
finance.yahoo.com - November 14 at 4:10 PM
Fortress Biotech EPS misses by $0.14, beats on revenueFortress Biotech EPS misses by $0.14, beats on revenue
seekingalpha.com - November 12 at 9:52 AM
Do Insiders Own Shares In Fortress Biotech, Inc. (NASDAQ:FBIO)?Do Insiders Own Shares In Fortress Biotech, Inc. (NASDAQ:FBIO)?
finance.yahoo.com - November 10 at 3:11 PM
Fortress Biotech, Inc. Common Stock (FBIO) Earnings Report DateFortress Biotech, Inc. Common Stock (FBIO) Earnings Report Date
www.nasdaq.com - November 8 at 4:00 PM
Checkpoint Therapeutics Announces Presentation of Anti-PD-L1 Cosibelimab Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual MeetingCheckpoint Therapeutics Announces Presentation of Anti-PD-L1 Cosibelimab Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - November 8 at 8:17 AM
Fortress Biotech, Inc. Common Stock (FBIO) Advanced ChartingFortress Biotech, Inc. Common Stock (FBIO) Advanced Charting
www.nasdaq.com - November 7 at 6:42 PM
This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.